Concord Medical Services Holdings Limited(CCM)Earnings, Financials & Key Ratios
CCM•NYSE
$5.14
$748461 mkt cap·Price updated May 7, 2026
AboutConcord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.Show more
- Revenue$384M-28.6%
- EBITDA-$401M-16.6%
- Net Income-$308M-3.6%
- EPS (Diluted)-2116.80-3.6%
- Gross Margin-20.62%-44.6%
- EBITDA Margin-104.54%-63.2%
- Operating Margin-138.6%-60.9%
- Net Margin-80.28%-44.9%
- ROE-18.32%-15.8%
- ROIC-7.74%-12.3%
- Debt/Equity2.43+28.8%
- Interest Coverage-2.47+11.8%
CCM Key Insights
Concord Medical Services Holdings Limited (CCM) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 14.1%
- ✓Trading at only 0.0x book value
✗Weaknesses
- ✗High debt to equity ratio of 2.4x
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
CCM Price & Volume
Concord Medical Services Holdings Limited (CCM) stock price & volume — 10-year historical chart
Loading chart...
CCM Growth Metrics
Concord Medical Services Holdings Limited (CCM) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-4.47%
5 Years14.12%
3 Years-7.53%
TTM-22.46%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM56.95%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM56.71%
Return on Capital
10 Years-8.76%
5 Years-9.82%
3 Years-10.91%
Last Year-12.23%
CCM Peer Comparison
Concord Medical Services Holdings Limited (CCM) competitors in Specialty chronic care clinics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 RDNT | 4.45B | 57.50 | -230 | 11.51% | 2.29% | 3.75% | 1.37 | |
 USPH | 897.04M | 59.00 | 41.55 | 16.33% | 1.52% | 1.36% | 0.55 | |
 AMSF | 569.48M | 30.30 | 12.27 | 2.63% | 14.27% | 9.68% | 0.00 | |
 ARAY | 34.82M | 0.29 | -18.91 | 2.68% | -10.76% | -77.48% | 2.17 | |
 MLAB | 586.29M | 106.12 | -294.78 | 11.47% | 1.51% | 2% | 1.14 | |
 ISRG | 161.07B | 453.49 | 57.62 | 20.51% | 28.15% | 16.89% | 0.02 | |
 MDT | 99.94B | 77.96 | 21.60 | 3.62% | 13% | 9.45% | 0.59 | |
 EW | 47.72B | 82.77 | 45.23 | 11.55% | 17.64% | 10.35% | 0.07 |
Compare CCM vs Peers
Concord Medical Services Holdings Limited (CCM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CCM Income Statement
Concord Medical Services Holdings Limited (CCM) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 455.04M | 330.98M | 190.9M | 198.36M | 223.01M | 485.63M | 472.08M | 537.4M | 383.96M | 365.76M |
| Revenue Growth % | -26.19% | -27.26% | -42.32% | 3.91% | 12.43% | 117.76% | -2.79% | 13.84% | -28.55% | -22.46% |
| Cost of Goods Sold | 286.54M | 232.98M | 171.14M | 214.19M | 209.93M | 542.53M | 624.49M | 614.01M | 463.12M | 407.61M |
| COGS % of Revenue | 62.97% | 70.39% | 89.65% | 107.98% | 94.13% | 111.72% | 132.28% | 114.26% | 120.62% | - |
| Gross Profit | 168.5M▲ 0% | 98M▼ 41.8% | 19.76M▼ 79.8% | -15.83M▼ 180.1% | 13.08M▲ 182.6% | -56.9M▼ 534.9% | -152.41M▼ 167.9% | -76.61M▲ 49.7% | -79.16M▼ 3.3% | -41.85M▲ 0% |
| Gross Margin % | 37.03% | 29.61% | 10.35% | -7.98% | 5.87% | -11.72% | -32.28% | -14.26% | -20.62% | -11.44% |
| Gross Profit Growth % | -35.97% | -41.84% | -79.83% | -180.1% | 182.65% | -534.89% | -167.87% | 49.74% | -3.33% | - |
| Operating Expenses | 337.13M | 309.85M | 319M | 421.46M | 329.08M | 401.42M | 372.64M | 386.38M | 453M | 437.22M |
| OpEx % of Revenue | 74.09% | 93.62% | 167.11% | 212.47% | 147.56% | 82.66% | 78.93% | 71.9% | 117.98% | - |
| Selling, General & Admin | 276M | 281.25M | 313.57M | 345.38M | 320.58M | 401.42M | 372.64M | 386.38M | 453M | 437.22M |
| SG&A % of Revenue | 60.65% | 84.98% | 164.26% | 174.11% | 143.75% | 82.66% | 78.93% | 71.9% | 117.98% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 61.12M | 28.6M | 5.43M | 76.09M | 8.5M | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -168.63M▲ 0% | -211.86M▼ 25.6% | -299.24M▼ 41.2% | -437.29M▼ 46.1% | -316M▲ 27.7% | -458.32M▼ 45.0% | -525.05M▼ 14.6% | -462.99M▲ 11.8% | -532.16M▼ 14.9% | -479.07M▲ 0% |
| Operating Margin % | -37.06% | -64.01% | -156.76% | -220.45% | -141.7% | -94.38% | -111.22% | -86.15% | -138.6% | -130.98% |
| Operating Income Growth % | -2836.2% | -25.64% | -41.25% | -46.13% | 27.74% | -45.04% | -14.56% | 11.82% | -14.94% | - |
| EBITDA | -40.81M | -122.4M | -254.23M | -380.94M | -245.22M | -363.86M | -401.86M | -344.16M | -401.4M | -358.51M |
| EBITDA Margin % | -8.97% | -36.98% | -133.17% | -192.04% | -109.96% | -74.92% | -85.12% | -64.04% | -104.54% | -98.02% |
| EBITDA Growth % | -126.94% | -199.9% | -107.7% | -49.84% | 35.63% | -48.38% | -10.44% | 14.36% | -16.63% | 52.5% |
| D&A (Non-Cash Add-back) | 127.81M | 89.45M | 45.02M | 56.35M | 70.79M | 94.46M | 123.19M | 118.83M | 130.76M | 120.55M |
| EBIT | -107.5M | -183.26M | -293.81M | -361.2M | -307.5M | -458.32M | -525.05M | -462.99M | -476.38M | -479.07M |
| Net Interest Income | -61.34M | -77.88M | -32.06M | -19.54M | -72.92M | -67.89M | -110.34M | -154.84M | -179.22M | -199.63M |
| Interest Income | 27.98M | 12.08M | 14.17M | 9.16M | 8.44M | 5.89M | 10.02M | 10.83M | 13.98M | 0 |
| Interest Expense | 89.33M | 89.96M | 46.23M | 28.7M | 81.36M | 73.79M | 120.36M | 165.67M | 193.2M | 199.63M |
| Other Income/Expense | -35.97M | -42.04M | 74M | 46.22M | -125.65M | -70.92M | -314.85M | -92.61M | -137.42M | -38.72M |
| Pretax Income | -204.6M▲ 0% | -253.9M▼ 24.1% | -225.25M▲ 11.3% | -391.08M▼ 73.6% | -441.65M▼ 12.9% | -529.24M▼ 19.8% | -839.9M▼ 58.7% | -555.59M▲ 33.8% | -669.58M▼ 20.5% | -517.79M▲ 0% |
| Pretax Margin % | -44.96% | -76.71% | -117.99% | -197.15% | -198.04% | -108.98% | -177.91% | -103.39% | -174.39% | -141.56% |
| Income Tax | 60.49M | 31.79M | 34.05M | -38.99M | -37.62M | -6.57M | -70.91M | -24.57M | -17.5M | 28.61M |
| Effective Tax Rate % | -29.56% | -12.52% | -15.12% | 9.97% | 8.52% | 1.24% | 8.44% | 4.42% | 2.61% | -5.53% |
| Net Income | -261.87M▲ 0% | -284.32M▼ 8.6% | -234.88M▲ 17.4% | -307.05M▼ 30.7% | -309.99M▼ 1.0% | -271.43M▲ 12.4% | -489.66M▼ 80.4% | -297.66M▲ 39.2% | -308.24M▼ 3.6% | -163.12M▲ 0% |
| Net Margin % | -57.55% | -85.9% | -123.04% | -154.79% | -139% | -55.89% | -103.72% | -55.39% | -80.28% | -44.6% |
| Net Income Growth % | -234.42% | -8.57% | 17.39% | -30.73% | -0.96% | 12.44% | -80.4% | 39.21% | -3.56% | 56.95% |
| Net Income (Continuing) | -265.08M | -285.68M | -259.3M | -352.09M | -404.03M | -522.67M | -768.99M | -531.02M | -652.08M | -546.4M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 65.59M | 80.87M | 1.84B | 2.01B | 3.06B | 4.11B | 3.88B | 3.87B | 3.9B | 3.96B |
| EPS (Diluted) | -1804.20▲ 0% | -1967.10▼ 9.0% | -2484.90▼ 26.3% | -3818.10▼ 53.7% | -4600.50▼ 20.5% | -5635.50▼ 22.5% | -3362.70▲ 40.3% | -2044.20▲ 39.2% | -2116.80▼ 3.6% | -1120.21▲ 0% |
| EPS Growth % | -244.44% | -9.03% | -26.32% | -53.65% | -20.49% | -22.5% | 40.33% | 39.21% | -3.55% | 56.71% |
| EPS (Basic) | -1804.20 | -1967.10 | -2484.90 | -3818.10 | -6987.00 | -5635.50 | -3362.70 | -2044.20 | -2116.80 | - |
| Diluted Shares Outstanding | 145.13K | 144.53K | 144.57K | 144.7K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K | 145.62K |
| Basic Shares Outstanding | 145.13K | 144.53K | 94.53K | 80.43K | 44.37K | 48.17K | 145.6K | 145.6K | 145.6K | 143.57K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
CCM Balance Sheet
Concord Medical Services Holdings Limited (CCM) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 1.19B | 1.11B | 1.23B | 282.49M | 676M | 584.48M | 759.8M | 617.21M | 983.97M | 1.03B |
| Cash & Short-Term Investments | 189.91M | 98.19M | 454.74M | 74.31M | 334.26M | 157.39M | 158.28M | 58.14M | 350.85M | 177.39M |
| Cash Only | 189.91M | 98.19M | 404.74M | 74.31M | 334.26M | 157.39M | 158.28M | 58.14M | 216.22M | 177.39M |
| Short-Term Investments | 0 | 0 | 50M | 0 | 0 | 0 | 0 | 0 | 134.62M | 0 |
| Accounts Receivable | 301.05M | 296.32M | 203.09M | 121.15M | 188.16M | 383.04M | 130.27M | 73.5M | 51.17M | 57.36M |
| Days Sales Outstanding | 241.48 | 326.78 | 388.32 | 222.92 | 307.96 | 287.89 | 100.72 | 49.92 | 48.64 | 54.15 |
| Inventory | 5.92M | 6.28M | 3.36M | 4.34M | 21.61M | 38.09M | 84.83M | 40.35M | 33.44M | 13.69M |
| Days Inventory Outstanding | 7.54 | 9.84 | 7.16 | 7.4 | 37.57 | 25.62 | 49.58 | 23.98 | 26.36 | 21.1 |
| Other Current Assets | 697.24M | 855.81M | 654.09M | 78.42M | 128.31M | 3.25M | 386.41M | 445.23M | 548.52M | 20.22M |
| Total Non-Current Assets | 2.03B | 2.35B | 3.36B | 4.01B | 4.66B | 5.65B | 5.25B | 5.44B | 5.74B | 5.71B |
| Property, Plant & Equipment | 775.34M | 793.57M | 1.22B | 2.55B | 3.2B | 3.35B | 3.45B | 4.13B | 4.01B | 4.19B |
| Fixed Asset Turnover | 0.59x | 0.42x | 0.16x | 0.08x | 0.07x | 0.15x | 0.14x | 0.13x | 0.10x | 0.09x |
| Goodwill | 0 | 0 | 165.17M | 210.44M | 213.66M | 581.88M | 575.43M | 575.43M | 572.22M | 572.22M |
| Intangible Assets | 459M | 455.73M | 895.17M | 532.49M | 522.82M | 1.07B | 762.09M | 323.29M | 680.37M | 273.98M |
| Long-Term Investments | 232.25M | 754.33M | 388.36M | 64.95M | 313.02M | 390.63M | 437.87M | 394.71M | 472.17M | 1.86B |
| Other Non-Current Assets | 65.37M | 8.58M | 4.89M | 661.14M | 107.47M | 13.58M | 23.19M | 11.43M | 5.87M | 612.48M |
| Total Assets | 3.23B▲ 0% | 3.47B▲ 7.3% | 4.59B▲ 32.3% | 4.3B▼ 6.3% | 5.33B▲ 24.1% | 6.23B▲ 16.8% | 6B▼ 3.6% | 6.05B▲ 0.8% | 6.73B▲ 11.1% | 6.73B▲ 0% |
| Asset Turnover | 0.14x | 0.10x | 0.04x | 0.05x | 0.04x | 0.08x | 0.08x | 0.09x | 0.06x | 0.05x |
| Asset Growth % | -10.31% | 7.33% | 32.32% | -6.28% | 24.13% | 16.79% | -3.61% | 0.82% | 11.11% | 25.56% |
| Total Current Liabilities | 951.06M | 1.11B | 870.26M | 627.45M | 512.12M | 804.52M | 1.12B | 1.95B | 2.13B | 2.45B |
| Accounts Payable | 2.04M | 4.56M | 5.44M | 8.28M | 18.63M | 102.51M | 146.75M | 129.24M | 199.39M | 112.19M |
| Days Payables Outstanding | 2.6 | 7.15 | 11.6 | 14.1 | 32.4 | 68.96 | 85.77 | 76.82 | 157.15 | 139.51 |
| Short-Term Debt | 724.62M | 794.47M | 249.2M | 0 | 148.88M | 299.35M | 512.58M | 1.04B | 1.03B | 1.37B |
| Deferred Revenue (Current) | 15.62M | 14.55M | 23.57M | 3.19M | 87.74M | 81.03M | 100.8M | 59.41M | 46.15M | 46.15M |
| Other Current Liabilities | 71.54M | 173.88M | 571M | 521.7M | 0 | 180M | 250.18M | 287.03M | 0 | 16.42M |
| Current Ratio | 1.26x | 1.00x | 1.41x | 0.45x | 1.32x | 0.73x | 0.68x | 0.32x | 0.46x | 0.46x |
| Quick Ratio | 1.25x | 1.00x | 1.41x | 0.44x | 1.28x | 0.68x | 0.60x | 0.30x | 0.45x | 0.45x |
| Cash Conversion Cycle | 246.43 | 329.48 | 383.88 | 216.21 | 313.14 | 244.55 | 64.53 | -2.92 | -82.15 | -64.25 |
| Total Non-Current Liabilities | 1.05B | 1.34B | 1.44B | 1.78B | 2.42B | 2.68B | 2.87B | 2.36B | 2.98B | 2.56B |
| Long-Term Debt | 464.27M | 799.05M | 720.04M | 1.29B | 1.97B | 2.2B | 2.49B | 2.01B | 2.71B | 2.27B |
| Capital Lease Obligations | 0 | 0 | 0 | 218.82M | 223.48M | 214.22M | 199.95M | 193.01M | 138.89M | 544.45M |
| Deferred Tax Liabilities | 49.66M | 73.58M | 165.65M | 165.44M | 153.34M | 184.42M | 112.58M | 99.54M | 82.87M | 82.87M |
| Other Non-Current Liabilities | 52.6M | 469.67M | 555.56M | 104.74M | 76.73M | 84.46M | 64.08M | 4.53M | 47.83M | 490.85M |
| Total Liabilities | 2B | 2.45B | 2.31B | 2.41B | 2.93B | 3.49B | 3.99B | 4.31B | 5.11B | 5.01B |
| Total Debt | 1.19B | 1.24B | 938.11M | 1.52B | 2.35B | 2.73B | 3.24B | 3.3B | 3.93B | 3.82B |
| Net Debt | 998.99M | 1.14B | 533.37M | 1.45B | 2.02B | 2.58B | 3.08B | 3.24B | 3.71B | 3.65B |
| Debt / Equity | 0.97x | 1.22x | 0.41x | 0.81x | 0.98x | 1.00x | 1.61x | 1.89x | 2.43x | 2.43x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | -10.66x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | -10.17x |
| Interest Coverage | -1.20x | -2.04x | -6.36x | -12.59x | -3.78x | -6.21x | -4.36x | -2.79x | -2.47x | -2.40x |
| Total Equity | 1.23B▲ 0% | 1.01B▼ 17.6% | 2.27B▲ 124.0% | 1.89B▼ 16.9% | 2.4B▲ 27.1% | 2.74B▲ 14.3% | 2.02B▼ 26.5% | 1.75B▼ 13.3% | 1.62B▼ 7.4% | 1.72B▲ 0% |
| Equity Growth % | -14.09% | -17.6% | 124.05% | -16.92% | 27.08% | 14.28% | -26.54% | -13.33% | -7.4% | -35.5% |
| Book Value per Share | 8487.18 | 7022.05 | 15729.02 | 13056.24 | 16489.22 | 18844.24 | 13843.80 | 11998.54 | 11110.91 | 11825.84 |
| Total Shareholders' Equity | 1.17B | 934.05M | 437.42M | -122.76M | -662.96M | -1.37B | -1.86B | -2.12B | -2.28B | -2.24B |
| Common Stock | 105K | 105K | 105K | 105K | 105K | 105K | 105K | 105K | 105K | 105K |
| Retained Earnings | -598.2M | -879.39M | -1.23B | -1.79B | -2.46B | -3.28B | -3.77B | -4.06B | -4.37B | -4.4B |
| Treasury Stock | -8K | -8K | -8K | -8K | -8K | -7K | -7K | -7K | -7K | -7K |
| Accumulated OCI | -87.97M | -47.42M | -88.62M | -97.28M | -46.43M | -29.5M | -27.77M | -65.42M | -77.35M | -70.4M |
| Minority Interest | 65.59M | 80.87M | 1.84B | 2.01B | 3.06B | 4.11B | 3.88B | 3.87B | 3.9B | 3.96B |
CCM Cash Flow Statement
Concord Medical Services Holdings Limited (CCM) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -78.08M | 26.73M | -38.59M | -195.35M | -229.77M | -359.31M | -216.69M | -276.47M | -397.75M | -397.75M |
| Operating CF Margin % | -17.16% | 8.08% | -20.22% | -98.48% | -103.03% | -73.99% | -45.9% | -51.45% | -103.59% | - |
| Operating CF Growth % | 55.42% | 134.24% | -244.36% | -406.2% | -17.62% | -56.38% | 39.69% | -27.59% | -43.87% | 0% |
| Net Income | -261.87M | -284.32M | -234.88M | -307.05M | -309.99M | -271.43M | -489.66M | -297.66M | -652.08M | -163.12M |
| Depreciation & Amortization | 129.01M | 94.71M | 54.63M | 65.81M | 80.3M | 104.08M | 132.81M | 128.45M | 130.76M | 0 |
| Stock-Based Compensation | 8.4M | 11.64M | 11.14M | 20.59M | 20.62M | 14.68M | -5.92M | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.65M | 0 |
| Other Non-Cash Items | 86.66M | 159.14M | -2.75M | 84.24M | 79.67M | -90.91M | 206.23M | -92.78M | 288.55M | 163.12M |
| Working Capital Changes | -40.28M | 45.56M | 133.27M | -58.94M | -100.37M | -115.74M | -60.16M | -14.49M | -149.33M | 0 |
| Change in Receivables | 9.92M | 43.41M | 48.38M | 3.57M | -6.17M | -64.45M | 644K | 36.45M | 12.02M | 0 |
| Change in Inventory | -1.92M | -554K | 1.8M | -1.83M | -14.45M | -4.35M | -46.75M | 44.49M | 6.5M | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 93.05M | 0 |
| Cash from Investing | -74.85M | -313.01M | -1B | -1.07B | -533.88M | -565.98M | -118.79M | -47.68M | -593.44M | 0 |
| Capital Expenditures | -117.99M | -289.1M | -764.4M | -700.92M | -504.7M | -760.58M | -383.77M | -115.7M | -400.67M | 0 |
| CapEx % of Revenue | 25.93% | 87.35% | 400.42% | 353.35% | 226.31% | 156.62% | 81.29% | 21.53% | 104.35% | - |
| Acquisitions | 26.2M | 0 | -528.74M | -525.68M | -8.34M | 1.57M | 0 | 0 | -92.94M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 16.94M | -23.91M | 292.78M | 155.1M | -20.84M | 193.03M | 264.98M | 68.02M | -160K | 0 |
| Cash from Financing | -117.92M | 189.9M | 1.2B | 513.27M | 1.14B | 642.45M | 383.09M | 257.65M | 1.15B | 0 |
| Debt Issued (Net) | 258.35M | 463.04M | -101.14M | 680.58M | 641.85M | 144.12M | 363.22M | 62.81M | 970.87M | 0 |
| Equity Issued (Net) | -30.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 510.52M | 0 |
| Dividends Paid | -285.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -30.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -60.04M | -273.14M | 1.3B | -167.31M | 496.46M | 498.32M | 19.87M | 194.84M | -335.36M | 0 |
| Net Change in Cash | 272.96M▲ 0% | -96.22M▼ 135.3% | 164.56M▲ 271.0% | -752.42M▼ 557.2% | 372.09M▲ 149.5% | -287.48M▼ 177.3% | 432K▲ 100.2% | -68.92M▼ 16054.6% | 146.56M▲ 312.6% | 0▲ 0% |
| Free Cash Flow | -196.07M▲ 0% | -262.37M▼ 33.8% | -802.99M▼ 206.1% | -896.27M▼ 11.6% | -734.47M▲ 18.1% | -1.12B▼ 52.5% | -600.47M▲ 46.4% | -392.17M▲ 34.7% | -808.58M▼ 106.2% | 0▲ 0% |
| FCF Margin % | -43.09% | -79.27% | -420.64% | -451.83% | -329.34% | -230.6% | -127.19% | -72.98% | -210.59% | - |
| FCF Growth % | 45.1% | -33.82% | -206.05% | -11.62% | 18.05% | -52.48% | 46.38% | 34.69% | -106.18% | - |
| FCF per Share | -1350.94 | -1815.30 | -5554.47 | -6194.00 | -5044.44 | -7691.58 | -4124.09 | -2693.50 | -5553.45 | -5553.45 |
| FCF Conversion (FCF/Net Income) | 0.30x | -0.09x | 0.16x | 0.64x | 0.74x | 1.32x | 0.44x | 0.93x | 1.29x | -0.00x |
| Interest Paid | 81.49M | 89.96M | 59.49M | 64.25M | 73.85M | 134.18M | 145.26M | 152.36M | 188.3M | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 3.26M | 0 | 3.01M | 898K | 148K | 0 |
CCM Key Ratios
Concord Medical Services Holdings Limited (CCM) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -19.65% | -25.31% | -14.28% | -14.75% | -14.45% | -10.55% | -20.58% | -15.82% | -18.32% | -9.77% |
| Return on Invested Capital (ROIC) | -5.38% | -7.24% | -9.04% | -10.67% | -6.11% | -7.06% | -7.56% | -6.89% | -7.74% | -7.74% |
| Gross Margin | 37.03% | 29.61% | 10.35% | -7.98% | 5.87% | -11.72% | -32.28% | -14.26% | -20.62% | -11.44% |
| Net Margin | -57.55% | -85.9% | -123.04% | -154.79% | -139% | -55.89% | -103.72% | -55.39% | -80.28% | -44.6% |
| Debt / Equity | 0.97x | 1.22x | 0.41x | 0.81x | 0.98x | 1.00x | 1.61x | 1.89x | 2.43x | 2.43x |
| Interest Coverage | -1.20x | -2.04x | -6.36x | -12.59x | -3.78x | -6.21x | -4.36x | -2.79x | -2.47x | -2.40x |
| FCF Conversion | 0.30x | -0.09x | 0.16x | 0.64x | 0.74x | 1.32x | 0.44x | 0.93x | 1.29x | -0.00x |
| Revenue Growth | -26.19% | -27.26% | -42.32% | 3.91% | 12.43% | 117.76% | -2.79% | 13.84% | -28.55% | -22.46% |
CCM Frequently Asked Questions
Concord Medical Services Holdings Limited (CCM) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Concord Medical Services Holdings Limited (CCM) reported $365.8M in revenue for fiscal year 2024. This represents a 113% increase from $171.8M in 2008.
Concord Medical Services Holdings Limited (CCM) saw revenue decline by 28.6% over the past year.
Concord Medical Services Holdings Limited (CCM) reported a net loss of $163.1M for fiscal year 2024.
Dividend & Returns
Concord Medical Services Holdings Limited (CCM) has a return on equity (ROE) of -18.3%. Negative ROE indicates the company is unprofitable.
Concord Medical Services Holdings Limited (CCM) had negative free cash flow of $808.6M in fiscal year 2024, likely due to heavy capital investments.
Explore More CCM
Concord Medical Services Holdings Limited (CCM) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates